Emerging roles of exosomal miRNAs in diabetes mellitus

X He, G Kuang, Y Wu, C Ou - Clinical and translational …, 2021 - Wiley Online Library
Exosomes are small extracellular vesicles 40–160 nm in diameter that are secreted by
almost all cell types. Exosomes can carry diverse cargo including RNA, DNA, lipids …

EndMT regulation by small RNAs in diabetes-associated fibrotic conditions: potential link with oxidative stress

R Giordo, YMA Ahmed, H Allam… - Frontiers in cell and …, 2021 - frontiersin.org
Diabetes-associated complications, such as retinopathy, nephropathy, cardiomyopathy, and
atherosclerosis, the main consequences of long-term hyperglycemia, often lead to organ …

Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes

AS Aghabozorgi, N Ahangari… - Journal of cellular …, 2019 - Wiley Online Library
Cardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality.
Standard therapies have failed to significantly increase patients' survival. Moreover, the …

MiR‐144 protects the heart from hyperglycemia‐induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis

L Tao, X Huang, M Xu, L Yang, F Hua - The FASEB Journal, 2020 - Wiley Online Library
Several lines of evidence have revealed the potential of microRNAs (miRNAs, miRs) as
biomarkers for detecting diabetic cardiomyopathy, although their functions in hyperglycemic …

Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications

N Satyadev, MI Rivera, NK Nikolov… - Frontiers in …, 2023 - frontiersin.org
Type 2 diabetes mellitus (T2DM) is one of the most prevalent metabolic disorders worldwide.
However, T2DM still remains underdiagnosed and undertreated resulting in poor quality of …

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy

U Ahmed, UA Ashfaq, M Qasim, I Ahmad, HU Ahmad… - PLoS …, 2021 - journals.plos.org
Diabetic Cardiomyopathy (DCM) is characterized by myocardial dysfunction caused by
diabetes mellitus. After-effects of diabetic cardiomyopathy are far more lethal than non …

Extracellular vesicles—Incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications

N Alexandru, A Procopciuc, A Vîlcu, IK Comariţa… - Reviews in Endocrine …, 2022 - Springer
Extracellular vesicles (EVs) are small anuclear vesicles, delimited by a lipid bilayer,
released by almost all cell types, carrying functionally active biological molecules that can …

[HTML][HTML] Diabetic Cardiomyopathy: Role of Cell Death, Exosomes, Fibrosis and Epicardial Adipose Tissue

A Galeone, A Annicchiarico, C Buccoliero… - International Journal of …, 2024 - mdpi.com
Diabetic cardiomyopathy (DCM) represents one of the typical complications associated with
diabetes. It has been described as anomalies in heart function and structure, with …

[PDF][PDF] A study of the effects of SGLT-2 inhibitors on diabetic cardiomyopathy through miR-30d/KLF9/VEGFA pathway.

WY Zhang, J Wang, AZ Li - European Review for Medical & …, 2020 - europeanreview.org
OBJECTIVE: The aim of this study was to observe the protective effects of SGLT-2 inhibitors
on diabetic cardiomyopathy. MATERIALS AND METHODS: After constructing a diabetic rat …

In vivo inhibition of miR-34a modestly limits cardiac enlargement and fibrosis in a mouse model with established type 1 diabetes-induced cardiomyopathy, but does …

BC Bernardo, GS Yildiz, H Kiriazis, CA Harmawan… - Cells, 2022 - mdpi.com
MicroRNA 34a (miR-34a) is elevated in the heart in a setting of cardiac stress or pathology,
and we previously reported that inhibition of miR-34a in vivo provided protection in a setting …